Shenzhen New Industries Biomedical Engineering Co., Ltd. Stock: price and insider trades · China
新产业
No insider purchase over the last 90 days. The latest, by 马杰, was filed 19 Feb 2024.
Since the insiders bought
- -16.8%Entry CN¥77.66 · Close at T+365 CN¥64.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Shenzhen New Industries Biomedical Engineering Co., Ltd. Strong Buy (bullish), based on 10 analysts. Average price target: CN¥65.91.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 15,000 shares100.0% of flowA股XSHESZSE:173000007746942560
- 100 shares100.0% of flowA股XSHESZSE:173000007330443360Canonical exit: 19 May 2024 (T+90)
- 30,400 shares9.4% of flowA股XSHESZSE:173000006875562180
- 80,000 shares19.7% of flowA股XSHESZSE:173000006487714400
- 340,400 shares90.6% of flowA股XSHESZSE:173000006169516580
- 40,000 shares10.1% of flowA股XSHESZSE:173000005972032030
- 2,000 shares2.5% of flowA股XSHESZSE:173000005573858900
- 67,100 shares97.5% of flowA股XSHESZSE:173000005126459870
- 56,000 shares47.2% of flowA股XSHESZSE:173000004762270460
- 58,000 shares52.8% of flowA股XSHESZSE:173000005126429470
- 250,000 shares67.9% of flowA股XSHESZSE:173000004487031650
- 8,430 shares2.3% of flowA股XSHESZSE:173000004485944800
12 of 12 declarations
About Shenzhen New Industries Biomedical Engineering Co., Ltd.
Shenzhen New Industries Biomedical Engineering Co., Ltd. (新产业), a Chinese health care company valued at CNY 41.9 billion and 48.5% held by its insiders, has 12 filings published between June 10, 2021 and June 12, 2024, from 6 filers. Almost everything is selling: 11 sales worth EUR 7.1 million (median EUR 329,197), against a single purchase of EUR 975, by 马杰 (监事) on February 19, 2024, or 8% of open-market trades.
The largest sale is 张小红's (高管): EUR 2,300,534 on December 29, 2022. 李婷华, the most frequent with 4 filings, sold EUR 2,209,332 on June 11, 2021 under the mention 核心技术人员, then EUR 639,627 on April 17, 2023 as 高管. 丁晨柳 (财务总监,副总裁) and 宋洪涛 (监事) have 2 filings each, 刘海燕 (高管) one.
Read moreShow less
Annual volume goes from 5 filings in 2021 to 3 in 2022, 2 in 2023 and 2 in 2024. The median publication delay is 0 days and no filing falls within the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
